Publication | Open Access
EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
52
Citations
0
References
2019
Year
UrologyMetastatic Urothelial CarcinomaInitial ResultsGenitourinary CancerMedicineEnfortumab VedotinImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!